NDRA (ENDRA Life Sciences) Days Payable: 0.00 (As of Mar. 2026)

What is ENDRA Life Sciences Days Payable?

ENDRA Life Sciences NDRA -2.90% 25 Days Payable is 0.00 as of Mar. 2026. GuruFocus rates NDRA with a GF Score™ of 25/100. The stock has 2 warning signs investors should review. Among 190 Medical Diagnostics & Research companies, ENDRA Life Sciences ranks worse than 526315.26% on this metric.

ENDRA Life Sciences's average Accounts Payable for the three months ended in Mar. 2026 was $0.42 Mil. ENDRA Life Sciences's Cost of Goods Sold for the three months ended in Mar. 2026 was $0.00 Mil.

The historical rank and industry rank for ENDRA Life Sciences's Days Payable or its related term are showing as below:

During the past 12 years, ENDRA Life Sciences's highest Days Payable was 1063.35. The lowest was 238.95. And the median was 651.15.

NDRA's Days Payable is not ranked ^*
in the Medical Diagnostics & Research industry.
Industry Median: 67.275
* Ranked among companies with meaningful Days Payable only.

ENDRA Life Sciences's Days Payable stayed the same from Mar. 2025 (0.00) to Mar. 2026 (0.00). stayed the same

ENDRA Life Sciences Days Payable Related Terms

ENDRA Life Sciences Days Payable Historical Data

* Premium members only.

The historical data trend for ENDRA Life Sciences's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ENDRA Life Sciences Days Payable Chart

ENDRA Life Sciences Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Days Payable

Get a 7-Day Free Trial

0.00

ENDRA Life Sciences Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Days Payable	Get a 7-Day Free Trial															0.00	0.00	0.00	0.00	0.00

NDRA vs BIAF, ADVB, MBAI: Days Payable Comparison

For the Diagnostics & Research subindustry, ENDRA Life Sciences's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ENDRA Life Sciences Days Payable vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, ENDRA Life Sciences's Days Payable distribution charts can be found below:

* The bar in red indicates where ENDRA Life Sciences's Days Payable falls into.

Save Embed

25GF Score

ENDRA Life Sciences Inc NDRA

Days Payable is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

ENDRA Life Sciences Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

ENDRA Life Sciences's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as

	Days Payable (A: Dec. 2025 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2024 )	+	Accounts Payable (A: Dec. 2025 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2025 )	*	Days in Period
=	( (0.27	+	0.383)	/	2 )	/	0	*	365
=	0.3265					/	0	*	365
=	N/A

ENDRA Life Sciences's Days Payable for the quarter that ended in Mar. 2026 is calculated as:

	Days Payable (Q: Mar. 2026 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Dec. 2025 )	+	Accounts Payable (Q: Mar. 2026 ))	/	count )	/	Cost of Goods Sold (Q: Mar. 2026 )	*	Days in Period
=	( (0.383	+	0.457)	/	2 )	/	0	*	365 / 4
=	0.42					/	0	*	365 / 4
=	N/A

Frequently Asked Questions Learn more about Days Payable →

What does a Days Payable of 0.00 mean?

ENDRA Life Sciences (NDRA) has a Days Payable of 0.00 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on ENDRA Life Sciences and its competitors. Over the past decade, ENDRA Life Sciences' Days Payable has ranged from 238.95 to 1,063.35. According to the industry distribution chart, ENDRA Life Sciences ranks #999999 out of 190 companies in the Medical Diagnostics & Research industry.

Is ENDRA Life Sciences' Days Payable too high?

ENDRA Life Sciences' current Days Payable is 0.00. Over the past 10 years, this metric has ranged from a low of 238.95 to a high of 1,063.35. Based on the distribution chart, ENDRA Life Sciences ranks #999999 out of 190 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers. Overall, ENDRA Life Sciences has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.

How does ENDRA Life Sciences' Days Payable compare to BIAF and ADVB?

According to the Medical Diagnostics & Research industry distribution chart, ENDRA Life Sciences ranks #999999 out of 190 companies for Days Payable. This places ENDRA Life Sciences in the lower half of its industry. The industry median Days Payable is 67.28. Historically, ENDRA Life Sciences' own Days Payable has ranged from 238.95 to 1,063.35 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Days Payable for a Medical Diagnostics & Research company?

The median Days Payable among Medical Diagnostics & Research companies is 67.28, based on 190 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Days Payable mean?

A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on ENDRA Life Sciences and its competitors. For the Medical Diagnostics & Research industry, the median Days Payable is 67.28 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ENDRA Life Sciences's current Days Payable is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is ENDRA Life Sciences stock overvalued right now?

ENDRA Life Sciences (NDRA) has a current Days Payable of 0.00. The current Days Payable is 0.00. ENDRA Life Sciences' overall GF Score™ is 25/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Days Payable calculated?

Days Payable is calculated from a company's financial statements. For ENDRA Life Sciences (NDRA), the current Days Payable is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

ENDRA Life Sciences Business Description

Industry Healthcare Medical Diagnostics & Research

Comparable Companies BIAF ADVB MBAI XWEL ISPC FUNI IVRO PRPH IDTA NSTM TMO DHR SHSE:603259 XSWX:LONN IDXX A NTRA WAT IQV ILMN

Address 3600 Green Court, Suite 350, Ann Arbor, MI, USA, 48105-1570

Website https://www.endrainc.com

ENDRA Life Sciences Inc is engaged in the development of thermo-acoustic enhanced ultrasound (TAEUS) technology to improve the capabilities of clinical diagnostic ultrasound. The company's technology is used to measure tissue composition, including the assessment of fat in the liver, and is being developed for additional clinical applications such as tissue temperature monitoring.

25GF Score

Get the complete analysis for NDRA

Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.12

Price

View NDRA Analysis

See Days Payable data for all stocks →